Aprotinin is a drug used to reduce blood loss and the need for transfusions during certain types of surgery, especially cardiothoracic surgery. It is a polypeptide derived from bovine lung tissue that works by inhibiting the activity of proteases, enzymes that can break down proteins, including those involved in the clotting process. Aprotinin is injected intravenously at the start of surgery and can help reduce blood loss and the need for blood transfusions, as well as the risks associated with them, such as infections and reactions to the donated blood.
Aprotinin was a medication previously used to prevent and control bleeding during and after surgery, particularly high-risk surgeries with significant blood loss potential. However, its use is no longer recommended due to safety concerns and the availability of safer alternatives. Here's a breakdown of its history and current status:
Previous Uses:
- Aprotinin was used in various surgical situations, including:
- Cardiac surgery: Open-heart surgery and other procedures involving the heart and major blood vessels.
- Liver surgery: Major liver resections and other procedures involving the liver.
- Aortic aneurysm repair: Surgical repair of a weakened bulge in the aorta, the main artery leaving the heart.
- Other high-risk surgeries: Procedures with a potential for significant blood loss.
Reasons for Decline:
- Increased risk of serious side effects: Studies showed an association between Aprotinin use and an increased risk of serious side effects, including:
- Blood clots: Increased risk of blood clots in the lungs (pulmonary embolism) and kidneys (renal failure).
- Allergic reactions: Life-threatening allergic reactions could occur in some individuals.
- Availability of safer alternatives: Newer medications and techniques for managing bleeding during surgery have been developed, offering similar effectiveness with a lower risk of side effects. These alternatives include:
- Tranexamic acid: Another medication used to control bleeding.
- Blood component therapy: Replacing specific blood components like red blood cells or platelets.
- Improved surgical techniques: Minimally invasive surgical techniques and advanced blood conservation strategies have helped reduce blood loss during surgery.
Current Status:
- Due to the safety concerns and availability of safer alternatives, Aprotinin is no longer recommended for any surgical procedures.
- Its use is strongly discouraged by major medical organizations like the American College of Surgeons and the European Society of Anaesthesiologists.
Important Note:
- This information is for educational purposes only and should not be interpreted as medical advice.
- If you have any questions or concerns about medications used during surgery, always consult with your surgeon or healthcare professional. They can provide personalized information based on your specific situation and medical history.